Skip to main content
. 2018 Oct 27;17(2):211–221. doi: 10.1007/s40200-018-0363-5

Table 2.

Prevalence (95% CI) of cardiometabolic risk factors according to different phenotypes of obesity and different metabolic phenotypes

Different phenotypes of obesity Different metabolic phenotypes of obesity
Sex Normal a
(n = 2938)
Only abdominal obesity b (n = 101) Only generalized Obesity c (n = 450) Combined obesity d (n = 312) MHNO e (n = 3202) MHO f (n = 340) MNHNO g (n = 120) MNHO h (n = 68)
Girls
Elevated TG 28.46 (26.2,30.8) 29.57 (23.7,36.2) 40 (28.2,53.1) 23.93 (17.1,32.4) 26.11 (24,28.3)* 19.71 (13.9,27.1)* 90.91 (81.1,95.9)* 76 (56.8,88.4)*
Elevated TC 4.87 (3.9,6.1) 4.35 (2.4,7.7) 6 (2.1,16.2) 4.27 (1.8,9.8) 4.9 (3.9,6.1) 5.11 (2.5,10.2) 3.64 (0.9,13.5) 4 (0.5,24)
Elevated LDL 18.57 (16.7,20.6) 16.09 (11.9,21.3) 14 (6.8,26.5) 20.51 (14, 23) 18.38 (16.6,20.3) 20.44 (14.7,27.8) 10.91 (5,22.3) 8 (1.9,27.5)
Low HDL 25.56 (23.3,28) 23.91 (18.7,30) 34 (22,48.4) 32.48 (24,42.2) 23.15 (21.1,25.4)* 25.5 (18.2,34.5)* 81.82 (69.3,90)* 76 (55.6,88.9)*
Dyslipidemia 53.67 (51.1,56.2) 53.04 (46.6,59.4) 60 (46.2,72.4) 62.39 (53.4,70.6) 51.71 (49.3,54.1)* 55.47 (46.6,64)* 100* 100*
High SBP 2.8 (2.4,3.2)* 2.34 (1.5,3.6)* 10.53 (6.8,15.9)* 7.55 (5.6,10)* 1.55 (1,2.3)* 4.38 (2,9.4)* 5.45 (1.7,15.8)* 8 (2,27.3)*
High DBP 8.9 (8.2,9.7)* 10.67 (8.8,12.9)* 15.13 (10.5,21.3)* 19.82 (16.7,23.4)* 6.9 (5.8,8.2)* 9.49 (5.7,15.4)* 38.18 (27,50.8)* 56 (35.5,74.6)*
High BP 10.06 (9.3,10.9)* 11.25 (9.3,13.5)* 19.74 (14.7,25.9)* 21.98 (18.6,25.8)* 7.48 (6.3,8.8)* 12.41 (7.9,18.8)* 38.18 (27, 50.8)* 56 (35.5,74.6)*
Elevated FBS 3.46 (2.7,4.4) 4.78 (2.7,8.3) 2 (0.3,13) 3.42 (1.3,8.6) 2.9 (2.2,3.8)* 0.73 (0.1,5)* 25.45 (16,37.9)* 16 (6.4,34.6)*
MetS 1.38 (0.9,2.2)* 15.8 (11.6,21.1)* 6.67 (2.1,18.9)* 18.8 (12.6,27.1)* 0 0 100* 100*
Boys
Elevated TG 26.54 (24.4,28.8) 27.27 (21.6,33.7) 25.49 (15.4,39.1) 30.26 (23.9,37.4) 24.29 (22.3,26.4)* 17.24 (12.5,23.2)* 83.08 (71,90.8)* 86.05 (71.7,93.7)*
Elevated TC 5.32 (4.3,6.5) 4.09 (2.1,7.7) 1.96 (0.3,12.7) 3.59 (1.7,7.3) 5.27 (4.3,6.4) 2.46 (1,5.7) 4.61 (1.5,13.3) 6.98 (2.3,19.4)
Elevated LDL 16.56 (14.8,18.4) 18.64 (14,24.7) 15.69 (8.1,28.2) 19.49 (14.5,25.6) 17.08 (15.4,18.9) 16.75 (12.2,22.5) 15.38 (8.5,26.2) 27.91 (16.1,43.8)
Low HDL 33.51 (31.4,35.6) 30 (24.3,36.4) 25.49 (15.3,39.2) 32.82 (26.7,39.6) 31.01 (29,33.1)* 22.17 (17.4,27.9)* 89.23 (78.6,94.9)* 74.42 (60,84.9)*
Dyslipidemia 56.9 (54.5,59.3) 59.09 (52.5,65.4) 54.9 (40.6,68.4) 58.46 (51.4,65.2) 55.66 (53.3,58)* 48.77 (41.9,55.7)* 98.46 (89.7,99.8)* 100*
High SBP 2.27 (1.9,2.7)* 2.88 (1.9,4.2)* 4.21 (2.1,8.1)* 8.13 (6.4,10.3)* 2.12 (1.5,2.9)* 3.94 (2,7.6)* 10.77 (5.2,20.9)* 18.6 (9.9,32.3)*
High DBP 8.96 (8.3, 9.7)* 12.14 (10.1,14.5)* 15.26 (11.1,20.7)* 19.01 (16.3,22)* 7.08 (6,8.3)* 13.3 (9.3,18.6)* 41.54 (29.8,54.3)* 44.19 (29.9,52.4)*
High BP 9.85 (9.1,10.6)* 13.22 (11.,15.6)* 16.32 (11.9,21.9)* 20.61 (17.8,23.7)* 7.8 (6.7,9.1)* 13.79 (9.7,19.2)* 44.62 (32.7,57.2)* 46.51 (32,61.6)*
Elevated FBS 4.93 (3.9,6.2) 4.54 (2.3,8.7) 3.92 (0.9,14.5) 3.59 (1.7,7.3) 3.63 (2.8,4.6)* 1.97 (0.7,5.1)* 36.92 (26.2,49.1)* 11.63 (4.8,25.4)*
MetS 2.13 (1.5,3)* 15.28 (11.1,20.6)* 1.96 (0.3,12.7)* 21.54 (15.9,28.4)* 0 0 100* 100*
Total
Elevated TG 27.47 (25.9,29.1) 32.67 (24.2,42.4) 28.44 (24.2,33.2) 27.88 (23.1,33.9) 25.17 (23.7,26.7)* 18.24 (14.4,22.8)* 86.67 (79,91.8)* 82.35 (71.2,89.8)*
Elevated TC 5.1 (4.4,5.9) 4.22 (2.7,6.5) 3.96 (1.6,9.2) 3.85 (2.2,6.6) 5.09 (4.4,5.8) 3.53 (2.1,5.9) 4.16 (1.7,9.6) 5.88 (2.2,14.7)
Elevated LDL 17.53 (16.2,18.9) 17.33 (14.1,21.2) 14.85 (9,23.6) 19.87 (15.8,24.6) 17.71 (16.5,19) 18.24 (14.5,21.1) 13.33 (8.1,21.1) 20.59 (11.9,33.1)
Low HDL 29.7 (28.2, 31.2) 26.7 (22.8,31.4) 29.7 (21.5,39.4) 32.7 (27.7,38.1) 27.2 (25.8,28.9)* 23.53 (19.3,28.4)* 85.83 (78.4,91)* 75 (63.6,83.7)*
Dyslipidemia 55.34 (53.5,57.1) 56 (51.1,60.7) 57.43 (47.4,66.9) 59.94 (54.6,65.1) 53.75 (52,55.5)* 51.47 (46.1,56.8)* 99.17 (94.3,99.9)* 100 *
High SBP 2.53 (2.3,2.8)* 2.6 (1.9,3.5)* 7 (4.8,10.1)* 7.9 (6.5,9.4)* 1.84 (1.4,2.3)* 4.12 (2.4,7)* 8.33 (4.6,14.7)* 14.71 (8.2,24.9)*
High DBP 8.9 (8.4,9.5)* 11.4 (9.9,13)* 15.2 (11.9,19.2)* 19.37 (17.3,21.6)* 6.99 (6.2,7.9)* 11.76 (8.8,15.6)* 40 (31.5, 49.2)* 48.53 (36.5,60.8)*
High BP 9.9 (9.4,10.5)* 12.2 (10.8,13.8)* 17.8 (14.4,21.9)* 21.22 (19.1,23.5)* 7.65 (6.8,8.5)* 13.24 (10.1,17.2)* 41.67 (33.1,50.8)* 50 (37.8,62.2)*
Elevated FBS 4.22 (3.5,5) 4.7 (3,7.2) 2.97 (0.9,8.8) 3.5 (1.9,6.3) 3.28 (2.7,4)* 1.47 (0.6,3.5)* 31.67 (24.1,40.3)* 13.24 (7,23.6)*
MetS 1.77 (1.3,2.3)* 15.54 (12.4,19.2)* 4.17 (1.5,10.7)* 20.51 (16.2,25.6)* 0 0 100* 100*

MetS: metabolic syndrome; FBS, fasting blood sugar; TC, total cholesterol; TG, triglycerides; LDL-C, low-density lipoprotein cholesterol; HDL-C, high-density lipoprotein cholesterol; SBP, systolic blood pressure; DBP, diastolic blood pressure; BMI: body mass index; WHtR: waist to height ratio; MHNO: Metabolic healthy non obese; MHO: Metabolic healthy obese; MNHNO: Metabolic non healthy non obese; MNHO: Metabolic non healthy obese

aNormal: 5th < BMI < 85th age sex specific percentile and WHtR<0.5

bOnly abdominal obesity: WHtR>0.5 and 5th < BMI < 85th age sex specific percentile

c Only generalized obesity: BMI > 95th age sex specific percentile and WHtR<0.5 and

d Combined Obesity: BMI > 95th age sex specific percentile and WHtR>0.5

e MHNO: Without metabolic syndrome and 5th < BMI < 85th age sex specific percentile

f MHO: Without metabolic syndrome and BMI > 95th age sex specific percentile

g MNHNO: having metabolic syndrome and 5th < BMI < 85th age sex specific percentile

h MNHO: Having metabolic syndrome and BMI > 95th age sex specific percentile

Dyslipidemia: at least one of thecomponents (TG, HDL, LDL, TC) are abnormal; Low HDL: HDL < 40 mg/dL (except in boys 15 ± 19 y old, that cut-off was <45 mg/dL); High LDL: LDL > 110 mg/dL; High TG: TG > 100 mg/dL; High TC: TC > 200 mg/dL; HighFBS: FBS > 100 mg/dL; High blood pressure: BP > 90th (adjusted by age, sex, height); Metabolic syndrome: ATP-III criteria.* P ≤ 0.05 is considered as significant